SCHEMBL21893483

SCHEMBL21893483

Cn1cc(N)c2cnccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 2/20 0.46
NFATC1 O95644 1/20 0.46
GSK3B P49841 1/20 0.46
HASPIN Q8TF76 1/20 0.41
HTR6 P50406 1/20 0.40
CDK5 Q00535 1/20 0.40
CDK5R1 Q15078 1/20 0.40
AXL P30530 1/20 0.39
EP300 Q09472 1/20 0.39
KAT2B Q92831 1/20 0.39
KAT8 Q9H7Z6 1/20 0.39
MAOA P21397 4/20 0.38
MAOB P27338 4/20 0.38
AURKA O14965 1/20 0.38
TTK P33981 1/20 0.38
AURKB Q96GD4 1/20 0.38
INCENP Q9NQS7 1/20 0.38
ACHE P22303 1/20 0.38
KDM4E B2RXH2 1/20 0.37
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20385498 0.85 DYRK1A (0.59) DYRK1ANFATC1GSK3BHASPINCDK5
SCHEMBL13041963 0.78 HTR6 (0.48) DYRK1ANFATC1GSK3BHASPINHTR6
SCHEMBL20674195 0.77 DYRK1A (0.46) DYRK1ANFATC1GSK3BHASPINHTR6
SCHEMBL22482127 0.77 HASPIN (0.61) DYRK1ANFATC1GSK3BHASPINHTR6
SCHEMBL26661966 0.77 CYP19A1 (0.38) DYRK1AHASPINHTR6AXLEP300
SCHEMBL26596988 0.77 HTR6 (0.38) DYRK1ANFATC1GSK3BHTR6AXL
SCHEMBL24656777 0.76 DYRK1A (0.45) DYRK1ANFATC1GSK3BHASPINHTR6
SCHEMBL24654861 0.74 DYRK1A (0.44) DYRK1ANFATC1GSK3BHASPINMAOA
SCHEMBL22558950 0.74 SIRT3 (0.49) DYRK1ANFATC1GSK3BHASPINKDM4E
SCHEMBL26652094 0.74 DYRK1A (0.38) DYRK1ANFATC1GSK3BHTR6AXL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4272832-A2 ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF Lakewood Amedex, Inc. (US) 2023-11-08 EP disclosed
US-11795192-B2 Antimicrobial compounds, compositions, and uses thereof Lakewood Amedex, Inc. (US) 2023-10-24 US disclosed
US-20210139522-A1 ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF Lakewood Amedex, Inc. 2021-05-13 US disclosed
WO-2020065613-A1 MONOACYLGLYCEROL LIPASE MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2020-04-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210139522-A1 ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF CFTR, ABCB11, CEL DYRK1A 4305/4885NFATC1 994/4885GSK3B 3393/4885
US-11795192-B2 Antimicrobial compounds, compositions, and uses thereof CAT, MPO, NISCH DYRK1A 4770/4885NFATC1 3119/4885GSK3B 4524/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.